| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2015 ( Subtotal = -$224,893 ) |
| | 2015 | 2014 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R43DA036398 | Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonists for Peripheral Pain | 000 | 1 | NIH | 1/15/2015 | -$224,893 |
|
| Issue Date FY: 2014 ( Subtotal = $224,893 ) |
| | 2014 | 2014 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R43DA036398 | Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonists for Peripheral Pain | 000 | 1 | NIH | 7/21/2014 | $224,893 |
| | 2014 | 2012 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 8 | NIH | 2/19/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $47,077 ) |
| | 2013 | 2012 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 8 | NIH | 8/28/2013 | $47,077 |
|
| Issue Date FY: 2012 ( Subtotal = $1,333,044 ) |
| | 2012 | 2012 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 8 | NIH | 9/11/2012 | $891,180 |
| | 2012 | 2012 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R41NS073378 | STROKE TREATMENT BY CHEMICALLY-INDUCED HYPOTHERMIA | 000 | 2 | NIH | 9/20/2012 | $441,864 |
|
| Issue Date FY: 2011 ( Subtotal = $1,441,864 ) |
| | 2011 | 2011 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R41NS073378 | STROKE TREATMENT BY CHEMICALLY-INDUCED HYPOTHERMIA | 000 | 1 | NIH | 9/19/2011 | $441,864 |
| | 2011 | 2011 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 7 | NIH | 8/30/2011 | $1,000,000 |
|
| Issue Date FY: 2010 ( Subtotal = $1,000,000 ) |
| | 2010 | 2010 | HALIMED PHARMACEUTICALS INC | 475-A EAST BAY STREET | CHARLESTON | SC | 29403 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 6 | NIH | 8/18/2010 | $1,000,000 |
|
|
